Turku Metabolomics Core Enhances MALDI Imaging with New Sprayer
The Turku Metabolomics Core, part of the Turku Bioscience Centre, has acquired a SunCollect MALDI Sprayer (Sunchrom) with support from the Research Council of Finland, the Sigrid Jusélius Foundation, and the European Innovation Council (EIC).
The new instrument ensures precise and reproducible matrix, enzyme and standard application for MALDI imaging and quantitative mass spectrometry, enabling the detection of a wider range of molecules with improved sensitivity and reproducibility. This upgrade strengthens the core’s ability to support diverse applications, ranging from basic science, and biomarker discovery to drug distribution studies.
The sprayer will benefit users of both the Metabolomics Core and the Proteomics Core, further advancing cutting-edge life science research at Turku Bioscience Centre.



Recent Posts
- New Funding for our Centre’s Researchers Warm congratulations to all for their funding! Cancer Foundation Finland Project grants Travel grants The Read moreDecember 12, 2025
- Sami Ventelä and Jukka Westermarck recognized by Medical Association Duodecim for their influential work. Medical association Duodecim selects each year persons that have been most influential in the field Read moreDecember 11, 2025
- Our affiliated Group Leader Rafa Najumudeen secures ERC Consolidator Grant The European Research Council (ERC) has awarded a Consolidator Grant to our affiliated Group Leader, Read moreDecember 9, 2025
- New computational tool helps scientists interpret complex single-cell data Researchers from Laura Elo’s group, have developed a new computational method to interpret complex single-cell Read moreNovember 17, 2025
- Carlos Rogério Figueiredo received the Young Investigator Award Carlos Rogério Figueiredo has received the Young Investigator Award from the Scandinavian Society for Immunology. Read moreNovember 4, 2025
- Participate to Open Hardware Workshop, sign up now! Access to research hardware remains a global challenge and it impacts also researchers in high-income Read moreNovember 3, 2025